title: Prostate specific membrane antigen mRNA in blood as a potential predictor of biochemical recurrence after radical prostatectomy.
abstract: We investigated whether the detection of prostate specific membrane antigen (PSMA) in blood preoperatively has predictive value for biochemical recurrence (BCR) after radical prostatectomy in patients with prostate cancer. All 134 patients scheduled to receive radical prostatectomy for prostate cancer were prospectively enrolled. The authors used nested reverse transcriptase-polymerase chain reaction (RT-PCR) assay to detect PSMA mRNA-bearing cells in peripheral blood, and analyzed the ability of PSMA mRNA positivity to predict BCR after surgery. PSMA-mRNA was detected in 24 (17.9%) patients by RT-PCR. Over a median follow-up of 20 months (range, 3 to 46 months), BCR developed in 15 patients (11.2%) and median time to BCR was 7 months (range, 3 to 25 months). Kaplan-Meier analysis revealed a significant difference between those positive or negative for PSMA in terms of recurrence-free actuarial probability (log rank P=0.0039). Multivariate analysis showed that positivity for PSMA mRNA (HR: 3.697, 95% CI 1.285-10.634, P=0.015) and a biopsy Gleason score of >or=7 (HR: 4.500, 95% CI 1.419-14.274, P=0.011) were independent preoperative predictors of BCR. The presence of PSMA mRNA in peripheral blood can be used to predict BCR after radical prostatectomy.
authors.affiliation: Center for Prostate Cancer, Goyang, Korea.
authors.forename: Jae Young
authors.initials: JY
authors.lastname: Joung
authors.forename: Kang Su
authors.initials: KS
authors.lastname: Cho
authors.forename: Han Soo
authors.initials: HS
authors.lastname: Chung
authors.forename: In-Chang
authors.initials: IC
authors.lastname: Cho
authors.forename: Jung Eun
authors.initials: JE
authors.lastname: Kim
authors.forename: Ho Kyung
authors.initials: HK
authors.lastname: Seo
authors.forename: Jinsoo
authors.initials: J
authors.lastname: Chung
authors.forename: Weon Seo
authors.initials: WS
authors.lastname: Park
authors.forename: Moon Kyung
authors.initials: MK
authors.lastname: Choi
authors.forename: Kang Hyun
authors.initials: KH
authors.lastname: Lee
mesh_terms: D000368:Aged; D000954:Antigens, Surface / Q000097:blood* / Q000235:genetics; D043425:Glutamate Carboxypeptidase II / Q000097:blood* / Q000235:genetics; D006801:Humans; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000097:blood / Q000175:diagnosis*; D011237:Predictive Value of Tests; D011468:Prostatectomy; D011471:Prostatic Neoplasms / Q000097:blood / Q000175:diagnosis* / Q000601:surgery; D012333:RNA, Messenger / Q000097:blood*; D020133:Reverse Transcriptase Polymerase Chain Reaction; D012720:Severity of Illness Index; D013997:Time Factors
chemical_list: D000954:Antigens, Surface; D012333:RNA, Messenger; C473848:FOLH1 protein, human; D043425:Glutamate Carboxypeptidase II
references.citation: Urology. 1996 Aug;48(2):326-34
references.pmid: 8753752
references.citation: Cancer Res. 1997 Jun 15;57(12):2321-4
references.pmid: 9192800
references.citation: Br J Urol. 1996 Mar;77(3):411-7
references.pmid: 8814848
references.citation: Ann N Y Acad Sci. 2000 Apr;906:110-23
references.pmid: 10818606
references.citation: JAMA. 2003 May 28;289(20):2695-700
references.pmid: 12771116
references.citation: Semin Surg Oncol. 2000 Jan-Feb;18(1):17-28
references.pmid: 10617893
references.citation: J Urol. 2001 Mar;165(3):851-6
references.pmid: 11176485
references.citation: Int J Urol. 2007 Jul;14(7):635-43
references.pmid: 17645609
references.citation: Urol Clin North Am. 1997 May;24(2):367-78
references.pmid: 9126234
references.citation: J Urol. 2006 Sep;176(3):991-5
references.pmid: 16890678
references.citation: Urology. 1994 Jun;43(6):765-75
references.pmid: 7515202
references.citation: Cancer Res. 1998 Apr 1;58(7):1456-9
references.pmid: 9537248
references.citation: J Urol. 2000 Jun;163(6):2022-9
references.pmid: 10799250
references.citation: Clin Cancer Res. 1997 Jul;3(7):1215-20
references.pmid: 9815802
references.citation: Int J Cancer. 1999 Aug 20;84(4):360-4
references.pmid: 10404086
references.citation: Cancer Res. 1993 Jan 15;53(2):227-30
references.pmid: 8417812
references.citation: BJU Int. 1999 Jul;84(1):112-7
references.pmid: 10444137
references.citation: Int J Cancer. 1995 Sep 4;62(5):552-8
references.pmid: 7665226
references.citation: Clin Chem. 1995 Dec;41(12 Pt 1):1698-704
references.pmid: 7497608
references.citation: J Urol. 1996 Nov;156(5):1560-6
references.pmid: 8863538
references.citation: Cancer Res. 1994 Dec 15;54(24):6306-10
references.pmid: 7527294
references.citation: Cancer Res. 1992 Nov 1;52(21):6110-2
references.pmid: 1382851